http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MD-994-Y

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34d526e3f8ebe3d0234b4465ff198bd3
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-12
filingDate 2015-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41a7436b306fe673c75b72845305cc40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d69b834109b919bc83f96ce9ffd0d0eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c9a8a7625c10f330c231c19695e7d21
publicationDate 2016-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MD-994-Y
titleOfInvention Treatment for cataracts complicated by anterior uveitis
abstract The invention relates to medicine, in particular to ophthalmology, and may be used for the treatment of complicated cataract with anterior uveitis. vehicle up to 1 ml, once, then 3 intravenous infusions are performed over 1 day with Dexamethasone solution, at a dose of 0.5 mg / kg body weight per day, dissolved in 200 ml of 0.9% NaCl solution , then the dose administered is halved and 2 to 3 infusions are performed over 1 day, then in the anterior chamber a single solution of Bevacizumab is administered, in a dose of 10 ... 15 mg, dissolved in 0.1 ... 0.2 ml of solution of 0.9% NaCl, more than 12 ... 15 days after the administration of Bevacizumab, a surgical procedure is performed by the phacoemulsification method with artificial crystalline implantation, taking r from the 1st postoperative day during 10… 14 days, ophthalmic drops of 0.1% Dexamethasone solution, 2 drops, 3 times daily are administered topically.
priorityDate 2015-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492800
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535608
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65478
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21800
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451794747

Total number of triples: 22.